Drug Type siRNA |
Synonyms- |
Target |
Mechanism ICAM-1 inhibitors(Intercellular adhesion molecule-1 inhibitors), LCN2 inhibitors(lipocalin 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | US | 01 Jan 2016 | |
Triple Negative Breast Cancer | Preclinical | US | 01 Jan 2016 | |
Triple Negative Breast Cancer | Preclinical | US | 01 Jan 2016 |